Clinical trialPhase 2Recruiting
Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate
Efficacy of Pancreatic Parenchymal N-Butyl-2-Cyanoacrylate Injection in Pancreaticojejunostomy After Pancreaticoduodenectomy: A Randomized Controlled Trial
- Outcome
- Ongoing
- Phase
- Phase 2
- Status
- Recruiting
- Study type
- Interventional
- Start
- 1 December 2025
- Expected end
- 20 December 2027
- Enrollment
- 90 participants
- Sites
- 1
- Primary outcomes
- Incidence of postoperative pancreatic fistula
- Sponsor
- Other
- Results posted
- No
- Last update
- 2 December 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try